NCT05133895View on ClinicalTrials.gov

Pilot Study of Tocilizumab Monotherapy for Active Chronic Periaortitis

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
Chronic PeriaortitisTocilizumab Monotherapy
Interventions
DRUG

Tocilizumab monotherapy

intravenous infusions of TCZ (8 mg/kg) at inclusion and then every 4 weeks for at least 3 months

Trial Locations (1)

Unknown

Yunyun Fei, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT05133895 - Pilot Study of Tocilizumab Monotherapy for Active Chronic Periaortitis | Biotech Hunter | Biotech Hunter